Abstract
Multiple, complementary techniques for tumor detection, including magnetic resonance, nuclear and optical imaging, are under active development; each approach has particular strengths and advantages. Efforts are also currently underway to develop bifunctional agents, so that a single molecule can be used for imaging, therapy, and monitoring the long-term tumor response. This chapter is mainly focused on illustrating the utility of certain tumor-avid photosensitizers in developing agents for tumor imaging [fluorescence, magnetic resonance imaging (MRI), positron emission tomography (PET)] and photodynamic therapy. Recent approaches for developing target-specific agents for photodynamic therapy (PDT) and in vivo tumor imaging are also briefly discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q. (1998) Photodynamic therapy. J Natl Cancer Inst, 90, 889–905.
Jori, G. (2004) Photodynamic therapy: basic and preclinical aspects. In: Horspool, W. and Francesco, L. (eds.) CRC Handbook of Organic Photochemistry and Photobiology. Boca Raton: CRC Press, Chapter 146.
Kessel, D. (2004) Delivery of photosensitizing agents. Adv. Drug Delivery Rev, 56(1), 7–8.
Dolmans, D. E. J. G., Fukumura, D., and Jain, R. K. (2003) Photodynamic therapy for cancer. Nat Rev Cancer, 3(5), 380.
Pandey, R. K. and Zheng, G. (2000) Porphyrins as photosensitizers in photodynamic therapy. Porphyrin Handb, 6, 157–230. and the references therein.
Pandey, R. K., James, N., Chen, Y., and Dobhal, M. P. (2008) Topics in Heterocyclic Chemistry. Berlin/Heidelberg: Springer, Vol. 14/2008, 41–74.
Henderson, B. W. and Dougherty, T. J. (1992) How does photodynamic therapy work? Photochem Photobiol, 55, 145–157.
Sternberg, E. D., Dolphin, D., and Bruckner, C. (1998) Porphyrin-based photosensitizers for the use in photodynamic therapy. Tetrahedron, 54(17), 4151–4202.
Sherman, W. M., Allen, C. M., and van Lier, J. E. (2000) Role of activated oxygen species in photodynamic therapy. Methods Enzymol, 319, 376–386.
MacDonald, I. and Dougherty, T. J. (2001) Basic principles of photodynamic therapy. J Porphyrins Phthalocyanines, 5(105), 2001–2011.
Weishaupt, K. R., Gomer, C. J., and Dougherty, T. J. (1976) Identification of singlet oxygen as the cytotoxic agent in photoinactivation of murine tumor. Cancer Res, 90, 889–899.
Ali, H. and Van Lier, J. E. (1999) Metal complexes as photo- and radiosensitizers. Chem Rev (Washington, DC), 99, 2379–2450.
Bonnett, R. (1995) Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Soc Rev, 24, 19–33.
Chen, Y., Sumlin, A., Morgan, J., Gryshuk, A., Oseroff, A., Henderson, B. W., Dougherty, T. J., and Pandey, R. K. (2004) Synthesis and photosensitizing efficacy of isomerically pure bacteriopurpurinimides. J Med Chem, 47, 4814–4817.
Ethirajan, M., Saenz, C., Gupta, A., Dobhal Mahabeer, P., and Pandey Ravindra, K. (2008) In: Hamblin, M. R. and Mroz, P. (eds.), Photosynsitizers for Photodynamic Therapy and Imaging: Advances in Photodynamic Therapy. Boston: Artech House Series.
Kessel, D. (2004) Delivery of photosensitizing agents. Adv Drug Delivery Rev, 56, 7–8.
Oleinick, N. L., Morris, R. L., and Belichenko, I. (2002) The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci, 1, 1–21.
Pandey, R. K., Goswami, L. N., Chen, Y., Gryshuk, A., Missert, J. R., Oseroff, A., and Dougherty, T. J. (2006) Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy. Lasers Surg Med, 38, 445–467.
Pandey, R. K. and Herman, C. K. (1998) Shedding some light on tumors. Chem Ind (London), 739–743.
Brown, S. B., Brown, E. A., and Walker, I. (2004) The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol, 5, 497–508.
Fingar, V. H., Wieman, J., Wiehle, S. A., and Cerrito, P. B. (1992) The role of microvasulature damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability and leukocyte adhesion. Cancer Res, 53, 4914–4924.
Fingar, V. H., Wieman, T. J., Karavolos, P. S., Doak, K. W., Ouellet, R., and van Lier, J. E. (1993) The effects of photodynamic therapy using different substituted phthalocyanines on vessel constriction, vessel leakage and tumor response. Photochem Photobiol, 58, 251.
Pandey, R. K., Sumlin, A. B., Constantine, S., Aoudia, M., Potter, W. R., Bellnier, D. A., Henderson, B. W., Rodgers, M. A., Smith, K. M., and Dougherty, T. J. (1996) Alkyl ether analogs of chlorophyll-a derivatives, Part 1: synthesis, photophysical properties and photodynamic efficacy. Photochem Photobiol, 64, 194–204.
Tarantola, R. M., Law, J. C., Recchia, F. M., Sternberg, P., Jr., and Agarwal, A. (2008) Photodynamic therapy as treatment of chronic idiopathic central serous chorioretinopathy. Lasers Surg Med, 40, 671–675.
Betz, C. S., Rauschning, W., Stranadko, E. P., Riabov, M. V., Albrecht, V., Nifantiev, N. E., and Hopper, C. (2008) Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas. Lasers Surg Med, 40, 300–311.
Berkovitch, G., Doron, D., Nudelman, A., Malik, Z., and Rephaeli, A. (2008) Novel multifunctional acyloxyalkyl ester prodrugs of 5-aminolevulinic acid display improved anticancer activity independent and dependent on photoactivation. J Med Chem, 51, 7356–7369.
Ohshiro, T., Nakajima, T., Sasaki, K., Fujii, S., and Taniguchi, Y. (2008) Photodynamic therapy with Talaporfin sodium for capillary hemangioma in a chicken comb model. Laser Surg Med, Suppl 20, Meeting Abstract, 339, 102.
Woodhams Josephine, H., MacRobert Alexander, J., Novelli, M., and Bown Stephen, G. (2006) Photodynamic therapy with WST09 (Tookad): quantitative studies in normal colon and transplanted tumours. Int J Can (Journal international du cancer), 118, 477–482.
Pandey, R. K. et al. Unpublished results.
Ke, M. S., Xue, L. -y, Feyes, D. K., Azizuddin, K., Baron, E. D., McCormick, T. S., Mukhtar, H., Panneerselvam, A., Schluchter, M. D., Cooper, K. D. et al. (2008) Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4. Photochem Photobiol, 84, 407–414.
Taquet, J. -p., Frochot, C., Manneville, V. and Barberi-Heyob, M. (2007) Phthalocyanines covalently bound to biomolecules for a targeted photodynamic therapy. Curr Med Chem, 14, 1673–1687.
Milgrom, L. R. (2008) Towards recombinant antibody-fragment targeted photodynamic therapy. Sci Prog, 91, 241–263.
Chen, B., Pogue, B. W., Hoopes, P. J., and Hasan, T. (2006) Vascular and cellular targeting for photodynamic therapy. Crit Rev Eukaryot Gene Expr, 16, 279–305.
Henry, J. M. and Isaacs, J. T. (1989) Synergistic enhancement of the efficacy of the bioreductively activated alkylating agent RSU-1164 in the treatment of prostatic cancer by photodynamic therapy. J Urol, 142, 165–170.
Urizzi, P., Allen, C. M., Langlois, R., Ouellet, R., La Madeleine, C., and Van Lier, J. E. (2001) Low-density lipoprotein-bound aluminum sulfophthalocyanine: targeting tumor cells for photodynamic therapy. J Porphyr Phthalocyanines, 5, 154–160.
Henderson, B. W., Bellnier, D. A., Greco, W. R., Sharma, A., Pandey, R. K., Vaughan, L. A., Weishaupt, K. R., and Dougherty, T. J. (1997) An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res, 57, 4000–4007.
Raab, O. (1900) Action of fluorescent materials on infusorial substances. Zeitschrift fuer Biologie (Munich), 39, 524–546.
Winkelman, J. and Rasmussen-Taxdal, D. S. (1960) Quantitative determination of porphyrin uptake by tumor tissue following parenteral administration. Bull Johns Hopkins Hosp, 107, 228–233.
Lipson, R. L. and Baldes, E. J. (1960) The photodynamic properties of a particular hematoporphyrin derivative. Arch Dermatol, 82, 508–516.
Dougherty, T. J., Grindey, G. B., Fiel, R., Weishaupt, K. R., and Boyle, D. G. (1975) Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst, 55, 115–121.
Dougherty, T. J., Grindley, G. B., and Weishaupt, K. R. (1975) Photoradiation therapy of animal tumors. Proc Am Assoc Cancer Res, 16, 29–29.
Yumita, N., Han, Q. -S., Kitazumi, I., and Umemura, S.-i. (2008) Sonodynamically-induced apoptosis, necrosis, and active oxygen generation by mono-l-aspartyl chlorin e6. Cancer Sci, 99, 166–172.
Gurfinkel, M., Thompson, A. B., Ralston, W., Troy, T. L., Moore, A. L., Moore, T. A., Gust, J. D., Tatman, D., Reynolds, J. S., Muggenburg, B. et al. (2000) Pharmacokinetics of ICG and HPPH-car for the detection of normal and tumor tissue using fluorescence, near-infrared reflectance imaging: a case study. Photochem Photobiol, 72, 94–102.
Foster, A. E., Kwon, S., Ke, S., Lu, A., Eldin, K., Sevick-Muraca, E., and Rooney, C. M. (2008) In vivo fluorescent optical imaging of cytotoxic T lymphocyte migration using IRDye800CW near-infrared dye. Appl Opt, 47, 5944–5952.
Poellinger, A., Martin Jan, C., Ponder Steven, L., Freund, T., Hamm, B., Bick, U., and Diekmann, F. (2008) Near-infrared laser computed tomography of the breast first clinical experience. Acad Radiol, 15, 1545–1553.
Hawrysz, D. J. and Sevick-Muraca, E. M. (2000) Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents. Neoplasia (New York, NY), 2, 388–417.
Mahmood, U., Tung, C. -H., Tang, Y., and Weissleder, R. (2002) Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in mice. Radiology, 224, 446–451.
Dougherty, T. J. and Levy, J. G. (2003) Photodynamic therapy (PDT) and clinical applications. Biomed Photonics Handb, 38/31–38/16.
Henderson, B. W. and Miller, A. C. (1986) Effects of the scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: comparison to ionizing radiation. Radiat Res, 108, 196.
Chin, W. W. L., Heng, P. W. S., and Olivo, M. (2007) Chlorin e6 – polyvinylpyrrolidone mediated photosensitization is effective against human non-small cell lung carcinoma compared to small cell lung carcinoma xenografts. BMC Pharmacol, 7, 15.
Chin, W. W. L., Heng, P. W. S., Thong, P. S. P., Bhuvaneswari, R., Hirt, W., Kuenzel, S., Soo, K. C., and Olivo, M. (2008) Improved formulation of photosensitizer chlorin e6 polyvinylpyrrolidone for fluorescence diagnostic imaging and photodynamic therapy of human cancer. Euro J Pharm Biopharma, 69, 1083–1093.
Pandey, R. K. et al. Unpublished results.
Chin, W. W. L., Lau, W. K. O., Heng, P. W. S., Bhuvaneswari, R., and Olivo, M. (2006) Fluorescence imaging and phototoxicity effects of new formulation of chlorin e6-polyvinylpyrrolidone. J Photochem Photobio B, Biol, 84, 103–110.
Jiang, F. -L., Wong, W. -K., Zhu, X. -J., Zhou, G. -J., Wong, W. -Y., Wu, P. -L., Tam, H. -L., Cheah, K. -W., Ye, C., and Liu, Y. (2007) Synthesis, characterization, and photophysical properties of some heterodimetallic bisporphyrins of ytterbium and transition metals – enhancement and lifetime extension of Yb3+ emission by transition-metal porphyrin sensitization. Euro J Inorg Chem, 3365–3374.
Gravier, J., Schneider, R., Frochot, C., Bastogne, T., Schmitt, F., Didelon, J., Guillemin, F., and Barberi-Heyob, M. (2008) Improvement of meta-tetra(hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. Synthesis and in vivo delivery studies. J Med Chem, 51(13), 3867–3877.
Li, G., Slansky, A., Dobhal, M. P., Goswami, L. N., Graham, A., Chen, Y., Kanter, P., Alberico, R. A., Spernyak, J., Morgan, J. et al. (2005) Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy. Bioconjug Chem, 16, 32–42.
Liu, J., Ohta, S. -I., Sonoda, A., Yamada, M., Yamamoto, M., Nitta, N., Murata, K., and Tabata, Y. (2007) Preparation of PEG-conjugated fullerene containing Gd3+ ions for photodynamic therapy. J Control Release, 117, 104–110.
Chang, T. C., Chang, C. -C., Kang, C. -C., Chen, C. -T., and Lin, Y. -C. (2007) A new BMVC-porphyrin binary photosensitizer for PDT selectivity. Mol Cancer Ther, 6, 3526S.
Chen, Y., Gryshuk, A., Achilefu, S., Ohulchansky, T., Potter, W., Zhong, T., Morgan, J., Chance, B., Prasad, P. N., Henderson, B. W. et al. (2005) A novel approach to a bifunctional photosensitizer for tumor imaging and phototherapy. Bioconjug Chem, 16, 1264–1274.
Chen, Y., Ohkubo, K., Zhang, M., Wenbo, E., Liu, W., Pandey, S. K., Ciesielski, M., Baumann, H., Erin, T., Fukuzumi, S. et al. (2007) Photophysical, electrochemical characteristics and cross-linking of STAT-3 protein by an efficient bifunctional agent for fluorescence image-guided photodynamic therapy. Photochem Photobiol Sci, 6, 1257–1267.
Isakau, H. A., Parkhats, M. V., Knyukshto, V. N., Dzhagarov, B. M., Petrov, E. P., and Petrov, P. T. (2008) Toward understanding the high PDT efficacy of chlorin e6-polyvinylpyrrolidone formulations: photophysical and molecular aspects of photosensitizer-polymer interaction in vitro. J Photochem Photobiol B, Biol, 92, 165–174.
Boisbrun, M., Vanderesse, R., Engrand, P., Olie, A., Hupont, S., Regnouf-de-Vains, J. -B., and Frochot, C. (2008) Design and photophysical properties of new RGD targeted tetraphenylchlorins and porphyrins. Tetrahedron, 64, 3494–3504.
Thomas, N., Tirand, L., Chatelut, E., Plenat, F., Frochot, C., Dodeller, M., Guillemin, F., and Barberi-Heyob, M. (2008) Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma bearing nude mice. Photochem Photobiol Sci, 7(4), 433–441.
Li, Y., Jang, W. -D., Nishiyama, N., Kishimura, A., Kawauchi, S., Morimoto, Y., Miake, S., Yamashita, T., Kikuchi, M., Aida, T. et al. (2007) Dendrimer generation effects on photodynamic efficacy of dendrimer porphyrins and dendrimer-loaded supramolecular nanocarriers. Chem Mater, 19, 5557–5562.
Pandey, S. K., Gryshuk, A. L., Sajjad, M., Zheng, X., Chen, Y., Abouzeid, M. M., Morgan, J., Charamisinau, I., Nabi, H. A., Oseroff, A. et al. (2005) Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible “see and treat” approach. J Med Chem, 48, 6286–6295.
Pandey, S. K., Sajjad, M., Chen, Y., Zheng, X., Yao, R., Missert, J. R., Batt, C., Nabi, H. A., Oseroff, A. R., and Pandey, R. K. (2009) Comparative positron-emission tomography (PET) imaging and phototherapeutic potential of 124I-labeled methyl-3-(1′-iodobenzyloxyethyl)pyropheophorbide-a vs the corresponding glucose and galactose conjugates. J Med Chem, 52, 445–455.
Pandey, S. K., Sajjad, M., Chen, Y., Pandey, A., Missert, J. R., Batt, C., Yao, R., Oseroff, A. R., and Pandey, R. K. (2009) Compared to purpurinimides, the pyropheophorbide containing an iodobenzyl group showed enhanced PDT efficacy and tumor imaging ability. Bioconjug Chem, 20(2), 274–282.
Kang, C. -C., Chen, C. -T., Cho, C. -C., Lin, Y. -C., Chang, C. -C., and Chang, T. -C. (2008) A dual selective antitumor agent and fluorescence probe: the binary BMVC-porphyrin photosensitizer. ChemMedChem, 3, 725–728.
Zheng, G., Graham, A., Shibata, M., Missert, J. R., Oseroff, A. R., Dougherty, T. J., and Pandey, R. K. (2001) Synthesis of beta -galactose-conjugated chlorins derived by enyne metathesis as galectin-specific photosensitizers for photodynamic therapy. J Org Chem, 66, 8709–8716.
Li, G., Pandey, S. K., Graham, A., Dobhal, M. P., Mehta, R., Chen, Y., Gryshuk, A., Rittenhouse-Olson, K., Oseroff, A., and Pandey, R. K. (2004) Functionalization of OEP-based benzochlorins to develop carbohydrate-conjugated photosensitizers. Attempt to target beta -galactoside-recognized proteins. J Org Chem, 69, 158–172.
Stefflova, K., Chen, J., and Zheng, G. (2007) Killer beacons for combined cancer imaging and therapy. Curr Med Chem, 14, 2110–2125.
Stefflova, K., Li, H., Chen, J., and Zheng, G. (2007) Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent. Bioconjug Chem, 18, 379–388.
Massoud, T. F. and Gambhir, S. S. (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev, 17, 545–580.
Chance, B. (1998) Near-infrared images using continuous, phase-modulated, and pulsed light with quantitation of blood and blood oxygenation. Ann N Y Acad Sci, 838, 29–45.
Chance, B., Cope, M., Gratton, E., Ramanujam, N., and Tromberg, B. (1998) Phase measurement of light absorption and scatter in human tissue. Rev Sci Instrum, 69, 3457–3481.
Choy, G., Choyke, P., and Libutti, S. K. (2003) Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Mol Imaging, 2, 303–312.
Achilefu, S., Dorshow, R. B., Bugaj, J. E., and Rajagopalan, R. (2000) Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. Invest Radiol, 35, 479–485.
Choi, H., Choi Seok, R., Zhou, R., Kung Hank, F., and Chen, I. W. (2004) Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol, 11, 996–1004.
Gao, X., Cui, Y., Levenson Richard, M., Chung Leland, W. K., and Nie, S. (2004) In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol, 22, 969–976.
Kelly, K., Alencar, H., Funovics, M., Mahmood, U., and Weissleder, R. (2004) Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res, 64, 6247–6251.
Sevick-Muraca, E. M., Godavarty, A., Houston, J. P., Thompson, A. B., and Roy, R. (2003) Near-infrared imaging with fluorescent contrast agents. Handb Biomed Fluoresc, 445–527.
Bouteiller, C., Clave, G., Bernardin, A., Chipon, B., Massonneau, M., Renard, P. -Y., and Romieu, A. (2007) Novel water-soluble near-infrared cyanine dyes: synthesis, spectral properties, and use in the preparation of internally quenched fluorescent probes. Bioconjug Chem, 18, 1303–1317.
Weissleder, R. and Ntziachristos, V. (2003) Shedding light onto live molecular targets. Nat Med (New York, NY, US), 9, 123–128.
Frangioni, J. V. (2003) In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol, 7, 626–634.
Klohs, J., Wunder, A., and Licha, K. (2008) Near-infrared fluorescent probes for imaging vascular pathophysiology. Basic Res Cardiol, 103, 144–151.
Ntziachristos, V. (2006) Fluorescence molecular imaging. Ann Rev Biomed Eng, 8, 1–33.
Sevick-Muraca, E. M., Kuwana, E., Godavatry, A., Houston, J. P., Thompson, J. P., and Roy, R. (2000) Near infra-red fluorescence imaging and spectroscopy in random media and tissues. In: Vo-Dinh, T. (ed.) Biomedical Photonics. Boca Raton: CRC Press.
Stranc, M. F., Sowa, M. G., Abdulrauf, B., and Mantsch, H. H. (1998) Assessment of tissue viability using near-infrared spectroscopy. Br J Plast Surg, 51, 210–217.
Klohs, J., Graefe, M., Graf, K., Steinbrink, J., Dietrich, T., Stibenz, D., Bahmani, P., Kronenberg, G., Harms, C., Endres, M. et al. (2008) In vivo imaging of the inflammatory receptor CD40 after cerebral ischemia using a fluorescent antibody. Stroke, 39, 2845–2852.
James, N. S., Goswami, L. N., Chen, Y., Sunar, U., Ohulchansky, T., and Pandey, R. K. Versatile Cyanine Dye Based Compounds for Tumor Imaging and Photodynamic Therapy. International Conference of Porphyrins and Phthalocyanines (ICPP-5), Moscow, July 2008.
Hilgenbrink, A. R. and Low, P. S. (2005) Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci, 94, 2135–2146.
Low, P. S., Henne, W. A., and Doorneweerd, D. D. (2008) Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res, 41, 120–129.
Lu, Y. and Low, P. S. (2002) Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Delivery Rev, 54, 675–693.
Leamon, C. P. and Low, P. S. (2001) Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov Today, 6, 44–51.
Salazar, M. D. A. and Ratnam, M. (2007) The folate receptor: what does it promise in tissue-targeted therapeutics? Cancer Metastasis Rev, 26, 141–152.
Mueller, C., Schibli, R., Krenning, E. P., and de Jong, M. (2008) Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer. J Nucl Med, 49, 623–629.
Sega, E. I. and Low, P. S. (2008) Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Rev, 27, 655–664.
Schneider, R., Schmitt, F., Frochot, C., Fort, Y., Lourette, N., Guillemin, F., Mueller, J. -F., and Barberi-Heyob, M. (2005) Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy. Bioorg Med Chem, 13, 2799–2808.
Hofmeister, V., Schrama, D., and Becker, J. C. (2007) Anti-cancer therapies targeting the tumor stroma. Cancer Immunol Immunother, 57, 1–17.
Lo, P. -C., Chen, J., Stefflova, K., Warren, M. S., Navab, R., Bandarchi, B., Mullins, S., Tsao, M., Cheng, J. D., and Zheng, G. (2009) Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers. J Med Chem, 52, 358–368.
Nestle, U., Weber, W., Hentschel, M., and Grosu, A. -L. (2009) Biological imaging in radiation therapy: role of positron emission tomography. Phys Med Biol, 54, R1–R25.
Magne, N., Chargari, C., Vicenzi, L., Gillion, N., Messai, T., Magne, J., Bonardel, G., and Haie-Meder, C. (2008) New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET. Cancer Treat Rev, 34, 671–681.
Verel, I., Visser Gerard, W. M., and van Dongen Guus, A. (2005) The promise of immuno-PET in radioimmunotherapy. J Nucl Med: official publication, Society of Nuclear Medicine, 46(Suppl 1), 164S–171S.
Laville, I., Pigaglio, S., Blais, J. -C., Doz, F., Loock, B., Maillard, P., Grierson David, S., and Blais, J. (2006) Photodynamic efficiency of diethylene glycol-linked glycoconjugated porphyrins in human retinoblastoma cells. J Med Chem, 49, 2558–2567.
Zhang, M., Zhang, Z., Blessington, D., Li, H., Busch, T. M., Madrak, V., Miles, J., Chance, B., Glickson, J. D., and Zheng, G. (2003) Pyropheophorbide 2-deoxyglucosamide: a new photosensitizer targeting glucose transporters. Bioconjug Chem, 14, 709–714.
Zhang, X., Morgan, J., Pandey, S. K., Chen, Y., Tracy, E., Baumann, H., Missert, J. R., Batt, C., Jackson, J., Bellnier, D. A., Henderson, B. W., and Pandey, R. K. (2009) Conjugation of HPPH to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo. J Med Chem, 52, 4306–4318.
Munoz, A. and Castillo, M. (2008) Indications for adult and pediatric magnetic resonance imaging gadolinium-enhanced cisternography and myelography: experience and review of the literature. Curr Med Imaging Rev, 4, 170–180.
Caravan, P., Ellison, J. J., McMurry, T. J., and Lauffer, R. B. (1999) Gadolinium (III) chelates as MRI contrast agents: structure, dynamics and applications. Chem Rev, 99, 2293–2352.
Hueber, M. M., Staubli, A. B., Kustedjo, K., Gray, M. H. B., Shih, J., Fraser, S. E., Jacobs, R. E., and Meade, T. J. (1998) Fluorescently detectable magnetic resonance imaging agents. Bioconjug Chem, 9, 242–249.
Acknowledgments
We are highly thankful to our collaborators over the years for their contributions. There name can be found in various citations. We also thank the NIH (CA55791, CA109914, CA114053, CA127639), Roswell Park Alliance, the Oncologic Foundation of Buffalo, and the shared resources of the RPCI (support Grant P30CA16056) for the financial support.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Pandey, R.K., James, N.S., Chen, Y., Missert, J., Sajjad, M. (2010). Bifunctional Agents for Imaging and Therapy. In: Gomer, C. (eds) Photodynamic Therapy. Methods in Molecular Biology, vol 635. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-697-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-60761-697-9_16
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-696-2
Online ISBN: 978-1-60761-697-9
eBook Packages: Springer Protocols